ProKidney Company Description

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.

Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes.

The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel.

ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

ProKidney Corp.

Country	United States
Founded	2015
Industry	Biological Products, Except Diagnostic Substances
Employees	204
CEO	Bruce Culleton

Contact Details

Address: 2000 Frontis Plaza Blvd. Winston-Salem, Delaware 27103 United States
Phone	336 999 7028
Website	prokidney.com

Stock Details

Ticker Symbol	PROK
Exchange	Mexican Stock Exchange
Share Class	Class A Shares
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2836

Key Executives

Name	Position
Bruce Culleton	Chief Executive Officer
James Coulston	Chief Financial Officer
Anu Biswas	Chief Operating Officer